XML 80 R51.htm IDEA: XBRL DOCUMENT
v3.21.2

Tender Agreement (Details Narrative) (10-K) - USD ($) | Aug. 12, 2020 | May 26, 2020 | May 06, 2020 | Jan. 10, 2020
--- | --- | --- | --- | ---
Alpha Capital Anstalt [Member] | Amalgamation Agreement [Member] | Common Stock [Member] |  |  |  |
Aggregate purchase price |  |  |  | $ 3,500,000
Enveric Biosciences, Inc. [Member] | Amalgamation Amendment Agreement [Member] | Common Stock [Member] | Series B Warrants [Member] |  |  |  |
Warrants to acquire shares of common stock |  |  | 8,100,000 |
Warrants exercise per share |  |  | $ 0.01 |
Enveric Biosciences, Inc. [Member] | Second Amalgamation Amendment Agreement [Member] | Series B Warrants [Member] |  |  |  |
Warrants to acquire shares of common stock |  | 8,100,000 |  |
Enveric Biosciences, Inc. [Member] | Second Amalgamation Amendment Agreement [Member] | Common Stock [Member] |  |  |  |
Number of shares issued during amalgamation |  | 3,675,035 |  |
Enveric Biosciences, Inc. [Member] | Tender Agreement [Member] |  |  |  |
Common stock beneficial ownership blocker, percentage | 9.99% |  |  |

X
- Definition Common stock beneficial ownership blocker, percentage. + References No definition available. + Details
Name: | amrh_CommonStockBeneficialOwnershipBlockerPercentage
Namespace Prefix: | amrh_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b)(4) -URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479 + Details
Name: | us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Number of shares of equity interests issued or issuable to acquire entity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b)(4) -URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479 + Details
Name: | us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644 + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | dei_LegalEntityAxis=amrh_AlphaCapitalAnstaltMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=amrh_AmalgamationAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=amrh_EnvericBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=amrh_AmalgamationAmendmentAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=amrh_SeriesBWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=amrh_SecondAmalgamationAmendmentAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=amrh_TenderAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |